Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Endocrine|January 2, 2025
Nongenetic risk factors for thyroid cancer: an umbrella review of evidenceGe Peng, Xiaohui Pan, Ziwei Ye, et al.Neurourology and Urodynamics|February 12, 2024
Multi-omics analyses uncover metabolic signatures and gene expression profiles of interstitial cystitis/bladder pain syndromeXianyanling Yi, Jin Li, Zeyu Han, et al.Frontiers in Public Health|July 31, 2023
Vitamin E intake and multiple health outcomes: an umbrella reviewTianyi Zhang, Xianyanling Yi, Jin Li, et al.Biochimica Et Biophysica Acta. Reviews on Cancer|July 28, 2023
RNA m6A modification in prostate cancer: A new weapon for its diagnosis and therapyZeyu Han, Xianyanling Yi, Jin Li, et al.Molecular Cancer|December 7, 2021
Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinomaHang Xu, Xiaonan Zheng, Shiyu Zhang, et al.Journal of the Science of Food and Agriculture|January 5, 2023
Carrot and carotene and multiple health outcomes: an umbrella review of the evidenceXianyanling Yi, Jin Li, Dazhou Liao, et al.International Journal of Surgery (London, England)|August 27, 2025
Impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and prognosis of major cancersYaxiong Tang, Lede Lin, Zeyu Han, et al.International Journal of Cancer|April 22, 2026
Clinical Benefit and Safety of Combined Immunotherapy and Targeted Therapy in Prostate CancerZeyu Han, Xianyanling Yi, Yaxiong Tang, et al.European Journal of Medical Research|September 1, 2023
Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER databaseYueting Zhu, Xia Liu, Yiyun Lin, et al.World Journal of Urology|June 3, 2025
Liquid biopsy for promoter methylation in prostate cancer: a promising non-invasive diagnostic weaponZeyu Han, Yize Zhao, Yaxiong Tang, et al.Pageof 4